Fierce Pharma

FEBRUARY 15, 2023

GSK was warned repeatedly about Zantac impurity but played down risks: Bloomberg esagonowsky Wed, 02/15/2023 - 09:02

352

352

MedCity News

FEBRUARY 15, 2023

Gen X is at the height of its spending potential. Its U.S. population of 65 million has saved a collective $13 trillion and owns 29% of the nation’s household wealth (versus just 6.4% owned by millennials).

Healthcare 142

Healthcare Healthcare Marketing 142

European Pharmaceutical Review

FEBRUARY 14, 2023

The COVID-19 pandemic led to an unparalleled paradigm shift in the use of and the incorporation of new technologies into our workflows. This was particularly apparent in academia and the pharmaceutical industry, where we have seen words such as Teams and Zoom becoming part of our new lexicon of language for meetings. Now we reach for these types of online meetings without a second thought, due to the clear productivity benefits they provide over real in-person meetings. 1 However, notwithstandin

Pharma 125

Pharma Training Pharmaceutical Education 125

Medgadget

FEBRUARY 13, 2023

Researchers at Columbia University’s Irving Medical Center have developed a method to create three-dimensional bioengineered skin grafts. To date, bioengineered skin is typically created in flat sheets. However, these are difficult to fit to complex anatomy, such as the hand, and so these researchers have designed a more sophisticated technique that combines laser scanning, 3D printing, and cell culture to create seamless three dimensional skin grafts.

Medical 123

Medical Patients Engineering 123

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA

Fierce Pharma

FEBRUARY 14, 2023

Pfizer CEO's texts with European Commission chief trigger new NYT lawsuit kdunleavy Tue, 02/14/2023 - 10:29

364

364

Pharmaceutical Technology

FEBRUARY 17, 2023

In January, amidst calls to improve patient safety by optimizing licensed drug formulations, the FDA released a draft guidance that signalled a departure from the most commonly used method of identifying a new therapy’s ideal dosage. The non-binding draft guidance gives insight into the agency’s current outlook and recommendations for standard and expedited programs in oncology.

FDA 111

FDA Pharmacology Patients Side effects 111

Medgadget

FEBRUARY 16, 2023

Researchers at MIT have developed an ingestible sensor that can reveal gastrointestinal motility issues, such as gastroparesis and gastroesophageal reflux disease. The technology is intended for use as an easy at-home method to diagnose such issues, which typically require more invasive and inconvenient procedures, such as endoscopy or X-ray imaging.

Patients 120

Patients Electronics Food 120

Fierce Pharma

FEBRUARY 14, 2023

ASCO: Takeda's Iclusig shows potential to become standard of care in acute lymphoblastic leukemia subtype kdunleavy Tue, 02/14/2023 - 14:33

263

263

MedCity News

FEBRUARY 16, 2023

Panelists at a recent healthcare conference expressed optimism about the automation technology that health plans, pharmacy benefit managers and providers can adopt to facilitate real-time data sharing. They said that such technology has potential to improve medication adherence, reduce costs and save time for both providers and payers.

Healthcare 128

Healthcare Healthcare Medical Management 128

European Pharmaceutical Review

FEBRUARY 13, 2023

Results from Phase III study KarMMa-3, showed chimeric antigen receptor (CAR) T-cell therapy Abecma (idecabtagene vicleucel) more than tripled progression-free survival compared with standard care for triple-class exposed multiple myeloma (MM). Abecma is the first and only CAR T-cell therapy to demonstrate superiority over standard regimens for this indication in a randomised, controlled Phase III trial.

Food and Drug Administration 111

Food and Drug Administration Patients FDA Safety 111

Medgadget

FEBRUARY 14, 2023

A team at Rice University has developed an automated feeding platform for mosquitoes that allows researchers to test different types of repellent and investigate mosquito-borne disease transmission. Traditionally, such mosquito research would require human volunteers or animal subjects for the mosquitos to feed on, but this is obviously inconvenient and a little distasteful.

Medicine 116

Medicine 116

Fierce Pharma

FEBRUARY 17, 2023

Blueprint gears up for Ayvakit expansion, with blockbuster sales on the line aliu Fri, 02/17/2023 - 10:17

Sales 313

Sales 313

MedCity News

FEBRUARY 17, 2023

Telehealth has been an essential tool during the pandemic but recent data shows that its utilization is decreasing as we move into 2021 and beyond. This decrease could lead to increased costs and decreased efficiency for healthcare systems as well as decreased access and poorer health outcomes for patients if nothing is done about it soon.

Healthcare 126

Healthcare Healthcare Patients Leads 126

Pharmaceutical Technology

FEBRUARY 13, 2023

While several therapeutics are available for treating symptoms associated with epilepsy, researchers and patients have strongly called out the need for more holistic treatments that would address the condition as a whole. Although recently approved drugs can treat seizures more safely, they do not treat the comorbidities that patients experience. Several biotech companies and researchers are now exploring medical devices and gene therapies to address not just common forms of epilepsy, but also r

Patients 105

Patients Pharmaceutical Medical Pharma 105

Medgadget

FEBRUARY 15, 2023

Researchers at Wake Forest University School of Medicine have tested a closed-loop acoustic stimulation neurotechnology in its ability to treat insomnia. The device in question has been developed by Cereset , a medtech company headquartered in Arizona. Insomnia is not just unpleasant, but can have significant long-term health consequences, including an increased risk of cardiovascular disease, obesity, and diabetes.

Medicine 111

Medicine Side effects Leads 111

Fierce Pharma

FEBRUARY 16, 2023

Ahead of next month's FDA decision, Emergent aces AdComm for over-the-counter Narcan nod fkansteiner Thu, 02/16/2023 - 14:12

FDA 276

FDA 276

MedCity News

FEBRUARY 16, 2023

Making operational changes to ease the unpredictable nature of respiratory season is the right thing to do for staff, for patients, and for the business. Digital solutions and better processes allow staff to work smarter and faster and prepare them for high-volume days ahead of time so they feel in control.

Patients 122

Patients 122

PharmaVoice

FEBRUARY 13, 2023

Why the recently appointed president of commercial solutions sees near limitless potential to expand Klick’s footprint across the life sciences — and how generative AI is playing a role.

105

105

Medgadget

FEBRUARY 17, 2023

Researchers at the Harvard Wyss Institute and the Dana-Farber Cancer Institute have developed a new method to prepare chimeric antigen receptor-T cells (CAR-T cells) for leukemia patients that could result in more effective treatment. CAR-T cells start life as T cells that are isolated from cancer patients, are stimulated and primed to recognize and attack cancer cells, expanded in number, and then reintroduced to the cancer patient with the goal that the cells will destroy their cancer.

Patients 108

Patients Leads Medicine 108

Fierce Pharma

FEBRUARY 13, 2023

Bayer's 3 business units 'perfectly positioned,' trade union says in resistance to potential breakup kdunleavy Mon, 02/13/2023 - 10:19

263

263

MedCity News

FEBRUARY 14, 2023

The increasing costs of labor and supplies are the top issues keeping healthcare CFOs up at night, according to a new report. Even though providers’ margins are currently quite tight, the report recommended that healthcare organizations adopt data analytics software to remedy these concerns and help with important decisions like how to effectively manage their existing workforce and where to shift care delivery models.

Healthcare 122

Healthcare Healthcare Management 122

Pharmaceutical Technology

FEBRUARY 14, 2023

The pharmaceutical industry continues to be a hotbed of innovation, with activity driven by the evolution of new treatment paradigms, and the gravity of unmet needs, as well as the growing importance of technologies such as pharmacogenomics, digital therapeutics, and artificial intelligence. In the last three years alone, there have been over 633,000 patents filed and granted in the pharmaceutical industry, according to GlobalData’s report on Innovation in Pharmaceuticals: Kidney disorder treatm

Pharmaceutical 105

Pharmaceutical Leads Medical Training 105

European Pharmaceutical Review

FEBRUARY 14, 2023

A market report by Reportlinker has indicated that the global highly potent active pharmaceutical ingredient (HPAPI) market is expected to reach $34.04 billion in 2026 at a CAGR of 8.5 percent. HPAPIs are substances that, at very low doses, cause a biological response. Traditionally, cytotoxic substances and sex hormones like oestrogen are used as examples of HPAPIs.

Marketing 105

Marketing Pharmaceutical Safety Manufacturing 105

Fierce Pharma

FEBRUARY 14, 2023

ASCO GU: Pfizer touts Talzenna's strong showing in PARP prostate cancer battle with AstraZeneca, J&J aliu Tue, 02/14/2023 - 14:11

263

263

MedCity News

FEBRUARY 16, 2023

Elation Health announced its acquisition of medical billing company Lightning MD — a deal the company made to help it become an all-in-one technology platform for primary care providers. Lighting MD stood out from other medical billing startups because of its ease of use, Elation CEO Kyna Fong said.

Medical 120

Medical Physicians 120

Pharmaceutical Technology

FEBRUARY 15, 2023

The pharmaceutical industry continues to be a hotbed of innovation, with activity driven by the evolution of new treatment paradigms and the gravity of unmet need, as well as the growing importance of technologies such as pharmacogenomics, digital therapeutics, and artificial intelligence. In the last three years alone, there have been over 633,000 patents filed and granted in the pharmaceutical industry, according to GlobalData’s report on Immuno-oncology: Leading companies in cancer monoclonal

Leads 104

Leads Pharmaceutical 104

Medgadget

FEBRUARY 16, 2023

Scientists at Brown University have designed an automated liquid chromatography tandem mass spectrometry (LC-MS/MS) system that allows clinicians to rapidly and easily process patient samples to determine levels of antidepressant drugs in the body. Getting the correct dose of antidepressant drugs into the bloodstream is important to ensure efficacy and avoid side-effects.

Side effects 100

Side effects Patients Leads Medicine 100

Fierce Pharma

FEBRUARY 17, 2023

After 3-plus years and multiple FDA approvals, Gilead's cell therapy head Christi Shaw leaving next month esagonowsky Fri, 02/17/2023 - 13:24

FDA 246

FDA 246

MedCity News

FEBRUARY 15, 2023

Analysts predict that disruptors could own as much as 30% of the $260 billion primary care market by 2030. A recent report from the American Hospital Association outlines major moves the healthcare industry should be watching this year from disruptors like Amazon, CVS and Walgreens — from billion-dollar acquisitions of primary care companies to expanding clinic locations to efforts in the home care space.

Healthcare 120

Healthcare Healthcare Marketing Medical 120

Impetus Digital

FEBRUARY 17, 2023

A French pharmaceutical team contacted Impetus Digital to help them establish a Virtual Steering Committee for patients with HIV/AIDS. They wanted to find a way to directly involve patients in driving strategy development and ensure that the patient voice is reflected in all of their patient-facing educational and support materials. Working closely together with the client’s internal team and local/national patient associations, Impetus supported the recruitment and contracting of eight steering

Patients 98

Patients Pharmaceutical Recruitment Education 98

Medgadget

FEBRUARY 14, 2023

Researchers at the Harvard Wyss Institute have developed an electrochemical device, called the eRapid sensor, that can assist clinicians in quickly characterizing someone’s COVID-19 infection, including identifying the infecting viral variant and the nature of someone’s immunity to the virus in terms of whether it is vaccine-mediated or natural immunity.

Patients 99

Patients Manufacturing Government Engineering 99

Fierce Pharma

FEBRUARY 17, 2023

As HQ move nears completion, Merck finds a buyer for its sprawling Kenilworth campus fkansteiner Fri, 02/17/2023 - 14:41

263

263

MedCity News

FEBRUARY 14, 2023

Some providers are still hesitant about certain technology advancements, but this article shows not only how critical tech will be to the healthcare industry at large, but also how it can help to lessen the toll of unpredictable crises, like the pandemic or the insurmountable nursing shortage we’re currently facing.

Healthcare 120

Healthcare Healthcare 120